Physician profile
Arthur Vayner
NPI 1619927472
$3,556.39
in general payments reported to CMS, 2019-2025
19 companies · $823 in 2025
The $823 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $742 · 2020: $421 · 2021: $96.66 · 2022: $209 · 2023: $581 · 2024: $684 · 2025: $823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,088.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,088.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $550.73 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $504.24 | 2022-2025 | Precision7, Rocklatan |
| Bausch & Lomb Americas INC. | $443.75 | 2023-2025 | Xiidra, Miebo, Vyzulta |
| Novartis Pharmaceuticals Corporation | $287.80 | 2019-2023 | |
| Allergan, INC. | $242.31 | 2019-2020 | |
| Biotissue Holdings INC. | $223.81 | 2023-2024 | |
| Tarsus Pharmaceuticals, INC. | $205.78 | 2024-2025 | Xdemvy |
| Eyevance Pharmaceuticals LLC | $195.34 | 2020-2022 | |
| Aerie Pharmaceuticals, INC. | $187.03 | 2019-2020 | |
| Shire North American Group INC | $178.69 | 2019 | |
| Sun Pharmaceutical Industries INC. | $154.02 | 2019-2025 | Cequa |
| Coopervision INC. | $101.43 | 2025 | Myday Contact Lens |
| Dompe US, INC. | $81.92 | 2024-2025 | Oxervate |
| Abbvie INC. | $62.81 | 2023-2024 | Lumigan |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $58.38 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $22.18 | 2023 | Iyuzeh |
| Sight Sciences, INC. | $19.53 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Vayner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.